Picture of Hemogenyx Pharmaceuticals logo

HEMO Hemogenyx Pharmaceuticals News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Brief: Hemogenyx Pharmaceuticals Announces Successful Completion Of Re-Manufacturing Of An Improved Lentivirus Devoid Of Splice Variants

Nov 15 (Reuters) - Hemogenyx Pharmaceuticals PLC
 HEMO.L :
    * HEMOGENYX PHARMACEUTICALS PLC - ANNOUNCES SUCCESSFUL
COMPLETION
OF RE-MANUFACTURING OF AN IMPROVED LENTIVIRUS DEVOID OF SPLICE
VARIANTS

Further company coverage:  HEMO.L 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Hemogenyx Pharmaceuticals

See all news